Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pivot Pharmaceuticals Inc (PVOTF)

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum

,

PVOTF : 0.1500 (+3.02%)
BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum

VANCOUVER , May 25, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) is pleased to announce that it has, as...

PVOTF : 0.1500 (+3.02%)
BETR : 12.00 (unch)
BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board

, /PRNewswire/ -BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has appointed Dr. to the Company's Scientific Advisory Board. Dr....

PVOTF : 0.1500 (+3.02%)
BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board

VANCOUVER , May 19, 2020 /PRNewswire/ -   BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has appointed Dr. Eleanor Fish...

PVOTF : 0.1500 (+3.02%)
BETR : 12.00 (unch)
BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that the journal Frontiers of Immunology ("") released the results of the...

PVOTF : 0.1500 (+3.02%)
BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon

VANCOUVER , May 15, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that the journal Frontiers of Immunology ("...

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that a third party study is scheduled to be released this Friday in the journal...

PVOTF : 0.1500 (+3.02%)
BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19

VANCOUVER , May 13, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that a third party study is scheduled to be released...

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
BetterLife Pharma Confirms Re-Pricing of Warrants

VANCOUVER , May 12, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) confirms the re-pricing of warrants issued pursuant to financings...

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group

VANCOUVER , May 11, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has appointed Dr. Mark Swaim to the...

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
BetterLife Pharma Enters into a Licensing Agreement

VANCOUVER , May 7, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has entered into an agreement to acquire...

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
BetterLife Pharma Provides Shareholder Update

VANCOUVER , April 7, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that the launch of its branded products is...

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
BetterLife Pharma Acquires Swiss Based Solmic AG with Unique Global Patent for Production of New Generation CBD based Biopharmaceuticals

VANCOUVER , Feb. 3, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced the acquisition of Swiss based Solmic AG with...

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
BetterLife Pharma strengthens Board of Directors and Management

The Company prepares for its upcoming launch of its branded product line in the US

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
BetterLife Pharma files site evidence package with Health Canada

VANCOUVER , Jan. 6, 2020 /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has submitted its site evidence package...

BETR : 12.00 (unch)
PVOTF : 0.1500 (+3.02%)
Pivot Pharmaceuticals re-brands as BetterLife Pharma Inc

Pivot Pharmaceuticals Inc. today announced its corporate name change to BetterLife Pharma Inc. The Company will change its ticker symbol to BETR. taking effect immediately. BetterLife is committed to becoming...

PVOTF : 0.1500 (+3.02%)
Pivot Pharmaceuticals re-brands as BetterLife Pharma Inc

VANCOUVER , Dec. 5, 2019 /PRNewswire/ - Pivot Pharmaceuticals Inc. today announced its corporate name change to BetterLife Pharma Inc. The Company will change its ticker symbol to BETR. taking effect...

PVOTF : 0.1500 (+3.02%)
BETR : 12.00 (unch)
Pivot Pharma Launches Canadian Cannabis and Nutraceutical Manufacturing Facility

Health Canada licensing documentation in preparation; production to start in next 90 days

CCAN : 0.0300 (+50.00%)
PVOTF : 0.1500 (+3.02%)
Pivot Pharma Launches Canadian Cannabis and Nutraceutical Manufacturing Facility

Health Canada licensing documentation in preparation; production to start in next 90 days

PVOTF : 0.1500 (+3.02%)
Pivot Pharma enters US CBD market with its proprietary CBD product line

Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) has entered into a contract manufacturing and supply agreement with F&B Cosmetics to manufacture Pivot's differentiated portfolio of CBD...

PVOTF : 0.1500 (+3.02%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -2.57 , SEDG -1.95 , THC -0.82 , TER -3.03 , LITE -1.54
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar